Smartwatch Analysis of Sleep Bruxism
Sleep Architecture Patterns in Individuals With Clinically Diagnosed Sleep Bruxism: A Pilot Smartwatch-Based Study
1 other identifier
observational
62
1 country
1
Brief Summary
This study aims to investigate the differences in sleep stages and total sleep duration between individuals diagnosed with sleep bruxism and healthy controls. This will be achieved through the use of smartwatches, which offer advantages such as rapid data acquisition, easy accessibility, long-term monitoring capabilities, and the potential to engage a large number of participants. It is anticipated that the findings of this study will serve as a pioneering effort in utilizing smartwatch applications for the continuous monitoring of sleep bruxism patients. Furthermore, it is expected to provide an alternative methodology for evaluating the impact of bruxism treatments on sleep quality, thereby contributing significantly to the existing literature. As smartwatches become more prevalent in health tracking, it is also envisioned that application developers will increasingly prioritize this area in their software development and updates
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 5, 2026
CompletedMarch 9, 2026
March 1, 2026
2 months
February 25, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Sleep Duration
Total time spent sleeping during the night as measured by a smartwatch (minutes). Results reported as the average total sleep duration over 7 consecutive nights.
Days 1-7 (average of 7 consecutive nights)
Secondary Outcomes (1)
Sleep Stages Distribution
Days 1-7 (average of 7 consecutive nights)
Study Arms (2)
Sleep Bruxism Group
This group will include participants diagnosed with sleep bruxism. Sleep stage data and total sleep duration will be collected using smartwatches.
Healthy Control Group
This group will include healthy individuals with no diagnosis of sleep bruxism. Sleep stage data and total sleep duration will be collected using smartwatches.
Interventions
Participants will wear a smartwatch to collect sleep stage data and total sleep duration over a specified period.
Eligibility Criteria
The study population will consist of two distinct groups: individuals diagnosed with sleep bruxism and healthy controls, both aged between 18 and 50 years. Participants with sleep bruxism will be recruited from the Oral and Maxillofacial Clinic of Cappadocia University, who have received a definitive diagnosis of sleep bruxism. Healthy control participants, without a history of sleep bruxism or any other sleep disorder, will be recruited from the general community via \[e.g., local advertisements, university staff/students, hospital staff\]. Both groups will be selected based on specific inclusion and exclusion criteria to ensure homogeneity within groups and to facilitate a clear comparison of sleep stages and total sleep duration using smartwatch data.
You may qualify if:
- Age 18-50 years.
- Complete natural dentition (excluding third molars).
- Willingness to wear a smartwatch for 7 consecutive nights.
You may not qualify if:
- High risk of Obstructive Sleep Apnea (OSA): Candidates with a STOP-Bang questionnaire score ≥3 or Body Mass Index (BMI) \>30 kg/m² were excluded. This was a critical step to ensure that any observed sleep fragmentation was not attributed to respiratory events \[21\].
- Systemic and Psychiatric Conditions: History of neurological disorders, psychiatric diagnosis, or systemic diseases (e.g., diabetes, hypertension, gastroesophageal reflux disease) that could alter sleep physiology.
- Medication Use: Current use of medications affecting the central nervous system or sleep architecture (e.g., antidepressants, sedatives, muscle relaxants).
- Lifestyle Factors: Excessive alcohol/caffeine consumption, shift work, or irregular sleep-wake schedules.
- Acute Pain: Presence of acute temporomandibular disorder (TMD) symptoms (e.g., painful restriction) to avoid pain-related sleep disturbances.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cappadocia University Faculty of Dentistry
Nevşehir, Nevşehir Province, 50040, Turkey (Türkiye)
Related Publications (1)
Kato T, Rompre P, Montplaisir JY, Sessle BJ, Lavigne GJ. Sleep bruxism: an oromotor activity secondary to micro-arousal. J Dent Res. 2001 Oct;80(10):1940-4. doi: 10.1177/00220345010800101501.
PMID: 11706956RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 25, 2026
First Posted
March 5, 2026
Study Start
January 1, 2025
Primary Completion
March 1, 2025
Study Completion
January 1, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL